Labcorp Return on Tangible Equity 2010-2024 | LH
Current and historical return on tangible equity values for Labcorp (LH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Labcorp Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-12-31 |
$0.75B |
$-1.81B |
-43.45% |
| 2024-09-30 |
$0.44B |
$-1.85B |
-26.12% |
| 2024-06-30 |
$0.45B |
$-1.55B |
-27.45% |
| 2024-03-31 |
$0.43B |
$-1.65B |
-31.22% |
| 2023-12-31 |
$0.42B |
$-1.61B |
-29.95% |
| 2023-09-30 |
$0.66B |
$-1.73B |
-84.66% |
| 2023-06-30 |
$0.83B |
$-0.55B |
-100.06% |
| 2023-03-31 |
$1.00B |
$-1.69B |
-92.07% |
| 2022-12-31 |
$1.28B |
$0.85B |
-125.52% |
| 2022-09-30 |
$1.76B |
$-1.93B |
-110.69% |
| 2022-06-30 |
$1.99B |
$-1.58B |
-143.42% |
| 2022-03-31 |
$2.10B |
$-1.42B |
-160.60% |
| 2021-12-31 |
$2.38B |
$-1.42B |
-177.92% |
| 2021-09-30 |
$2.76B |
$-1.14B |
-178.22% |
| 2021-06-30 |
$2.88B |
$-1.25B |
-137.75% |
| 2021-03-31 |
$2.64B |
$-1.53B |
-95.67% |
| 2020-12-31 |
$1.56B |
$-2.28B |
-45.13% |
| 2020-09-30 |
$0.85B |
$-3.30B |
-21.33% |
| 2020-06-30 |
$0.36B |
$-3.95B |
-8.46% |
| 2020-03-31 |
$0.32B |
$-4.27B |
-7.16% |
| 2019-12-31 |
$0.82B |
$-4.33B |
-18.50% |
| 2019-09-30 |
$0.76B |
$-4.61B |
-16.99% |
| 2019-06-30 |
$0.85B |
$-4.72B |
-19.75% |
| 2019-03-31 |
$0.90B |
$-4.16B |
-21.11% |
| 2018-12-31 |
$0.88B |
$-4.30B |
-19.90% |
| 2018-09-30 |
$1.41B |
$-4.11B |
-31.02% |
| 2018-06-30 |
$1.27B |
$-4.44B |
-25.67% |
| 2018-03-31 |
$1.22B |
$-4.93B |
-24.74% |
| 2017-12-31 |
$1.23B |
$-4.76B |
-25.74% |
| 2017-09-30 |
$0.70B |
$-5.62B |
-15.11% |
| 2017-06-30 |
$0.71B |
$-4.39B |
-16.42% |
| 2017-03-31 |
$0.73B |
$-4.32B |
-16.97% |
| 2016-12-31 |
$0.71B |
$-4.32B |
-16.37% |
| 2016-09-30 |
$0.66B |
$-4.32B |
-14.90% |
| 2016-06-30 |
$0.63B |
$-4.26B |
-14.02% |
| 2016-03-31 |
$0.60B |
$-4.50B |
-12.74% |
| 2015-12-31 |
$0.44B |
$-4.58B |
-8.90% |
| 2015-09-30 |
$0.45B |
$-4.72B |
-10.63% |
| 2015-06-30 |
$0.43B |
$-5.01B |
-12.36% |
| 2015-03-31 |
$0.40B |
$-5.37B |
-14.76% |
| 2014-12-31 |
$0.51B |
$-1.76B |
-26.88% |
| 2014-09-30 |
$0.52B |
$-1.79B |
-26.01% |
| 2014-06-30 |
$0.53B |
$-1.96B |
-25.77% |
| 2014-03-31 |
$0.54B |
$-2.10B |
-26.41% |
| 2013-12-31 |
$0.57B |
$-2.10B |
-29.30% |
| 2013-09-30 |
$0.57B |
$-2.03B |
-29.96% |
| 2013-06-30 |
$0.57B |
$-1.93B |
-30.75% |
| 2013-03-31 |
$0.57B |
$-1.76B |
-32.01% |
| 2012-12-31 |
$0.58B |
$-1.85B |
-33.15% |
| 2012-09-30 |
$0.60B |
$-1.83B |
-34.26% |
| 2012-06-30 |
$0.58B |
$-1.65B |
-34.15% |
| 2012-03-31 |
$0.55B |
$-1.70B |
-31.98% |
| 2011-12-31 |
$0.52B |
$-1.80B |
-29.16% |
| 2011-09-30 |
$0.52B |
$-1.69B |
-28.95% |
| 2011-06-30 |
$0.52B |
$-1.74B |
-31.70% |
| 2011-03-31 |
$0.55B |
$-1.89B |
-36.82% |
| 2010-12-31 |
$0.56B |
$-1.81B |
-42.56% |
| 2010-09-30 |
$0.57B |
$-1.15B |
-49.80% |
| 2010-06-30 |
$0.56B |
$-1.16B |
-48.79% |
| 2010-03-31 |
$0.54B |
$-1.14B |
-48.94% |
| 2009-12-31 |
$0.54B |
$-1.13B |
-48.69% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$19.480B |
$13.009B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
